PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care
Phase of Trial: Phase IV
Latest Information Update: 07 Aug 2017
At a glance
- Drugs PG 2 (Primary)
- Indications Fatigue
- Focus Therapeutic Use
- Sponsors PhytoHealth
- 01 Aug 2017 Status changed from recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 09 May 2017 Planned number of patients changed from 250 to 350.